Weekly paclitaxel, gemcitabine, and external irradiation followed by randomized farnesyl transferase inhibitor R115777 for locally advanced pancreatic cancer.
Onco Targets Ther., 5:161-70 (2012)
Five year results of US intergroup/RTOG 9704 with postoperative CA 19-9 â‰¤90 U/mL and comparison to the CONKO-001 trial.
Int. J. Radiat. Oncol. Biol. Phys., Nov;84(3):e291-7 (2012)
Pancreatic Adenocarcinoma, version 2.2012: featured updates to the NCCN Guidelines.
J Natl Compr Canc Netw., Jun;10(6):703-13 (2012)
The anatomic course of the first jejunal branch of the superior mesenteric vein in relation to the superior mesenteric artery.
Int J Surg Oncol., 2012:538769 (2012)
Phase II trial of neoadjuvant/adjuvant imatinib mesylate for advanced primary and metastatic/recurrent operable gastrointestinal stromal tumors: long-term follow-up results of Radiation Therapy Oncology Group 0132.
Ann. Surg. Oncol., Apr;19(4):1074-80 (2012)
Significance of pathologic response to preoperative therapy in pancreatic cancer.
Ann. Surg. Oncol., Dec;18(13):3601-7 (2011)
Initial experience with laparoscopic hepatic resection at a comprehensive cancer center.
Surg Endosc., Feb;26(2):480-7 (2012)
Minimally invasive pancreatic surgery of the entire gland: initial experience.
Minerva Chir., Aug;66(4):269-80 (2011)
Clinical Stage T1 micropapillary urothelial carcinoma presenting with metastasis to the pancreas.
Urology., Feb;79(2):e9-10 (2012)
Video: laparoscopic Whipple procedure with a two-layered pancreatojejunostomy.
Surg Endosc., Oct;25(10):3446-7 (2011)
Video: laparoscopic right hepatectomy and partial resection of the diaphragm for liver metastases.
Surg Endosc., Oct;25(10):3441-3 (2011)
Fluorouracil-based chemoradiation with either gemcitabine or fluorouracil chemotherapy after resection of pancreatic adenocarcinoma: 5-year analysis of the U.S. Intergroup/RTOG 9704 phase III trial.
Ann. Surg. Oncol., May;18(5):1319-26 (2011)
Failure to adhere to protocol specified radiation therapy guidelines was associated with decreased survival in RTOG 9704--a phase III trial of adjuvant chemotherapy and chemoradiotherapy for patients with resected adenocarcinoma of the pancreas.
Int. J. Radiat. Oncol. Biol. Phys., Feb;82(2):809-16 (2012)
Laparoscopic pancreatoduodenectomy: a review of 285 published cases.
Ann. Surg. Oncol., May;18(5):1335-41 (2011)
The influence of total nodes examined, number of positive nodes, and lymph node ratio on survival after surgical resection and adjuvant chemoradiation for pancreatic cancer: a secondary analysis of RTOG 9704.
Int. J. Radiat. Oncol. Biol. Phys., Dec;81(5):1328-35 (2011)
J Natl Compr Canc Netw., Sep;8(9):972-1017 (2010)
Defining venous involvement in borderline resectable pancreatic cancer.
Ann. Surg. Oncol., Nov;17(11):2832-8 (2010)
Laparoscopic completion radical cholecystectomy for T2 gallbladder cancer.
Surg Endosc., Dec;24(12):3221-3 (2010)
Status of neoadjuvant therapy for resectable pancreatic cancer.
Surg. Oncol. Clin. N. Am., Apr;19(2):411-8 (2010)
Laparoscopic radical cholecystectomy and Roux-en-Y choledochojejunostomy for gallbladder cancer.
Surg Endosc., Jul;24(7):1766-8 (2010)
Preoperative versus postoperative adjuvant therapy for adenocarcinoma of the pancreas.
Adv Surg., 43:189-98 (2009)
Editorial: Combined modality treatment of resectable and borderline resectable pancreas cancer: expert consensus conference.
Ann. Surg. Oncol., Jul;16(7):1757-9 (2009)
Proteomic analyses of pancreatic cyst fluids.
Pancreas., Mar;38(2):e33-42 (2009)
Postresection CA 19-9 predicts overall survival in patients with pancreatic cancer treated with adjuvant chemoradiation: a prospective validation by RTOG 9704.
J. Clin. Oncol., Dec;26(36):5918-22 (2008)
Phase II trial of neoadjuvant/adjuvant imatinib mesylate (IM) for advanced primary and metastatic/recurrent operable gastrointestinal stromal tumor (GIST): early results of RTOG 0132/ACRIN 6665.
J Surg Oncol., Jan;99(1):42-7 (2009)
Fibroblast activation protein and its relationship to clinical outcome in pancreatic adenocarcinoma.
Pancreas., Aug;37(2):154-8 (2008)
Survival after pancreatectomy with major arterial resection and reconstruction.
Ann. Surg. Oncol., May;15(5):1399-406 (2008)
Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: a randomized controlled trial.
JAMA., Mar;299(9):1019-26 (2008)
Chemoradiation followed by chemotherapy before resection for borderline pancreatic adenocarcinoma.
Am. J. Surg., Mar;195(3):318-21 (2008)
Full-dose gemcitabine with concurrent radiation therapy in patients with nonmetastatic pancreatic cancer: a multicenter phase II trial.
J. Clin. Oncol., Feb;26(6):942-7 (2008)
Neoadjuvant therapy in pancreatic cancer.
Cancer Invest., Jun;25(4):267-73 (2007)
Significance of common hepatic artery lymph node metastases during pancreaticoduodenectomy for pancreatic head adenocarcinoma.
Ann. Surg. Oncol., Aug;14(8):2330-6 (2007)
Resection of isolated pelvic recurrences after colorectal surgery: long-term results and predictors of improved clinical outcome.
Ann. Surg. Oncol., Jul;14(7):2000-9 (2007)
Nonneoplastic celiac axis occlusion in patients undergoing pancreaticoduodenectomy.
Am. J. Surg., Mar;193(3):341-4; discussion 344 (2007)
Resection of isolated pelvic recurrences after colorectal surgery: long-term results and predictors of improved clinical outcome.
Ann. Surg. Oncol., Mar;14(3):1081-91 (2007)
Isolation and characterization of circulating tumor cells in patients with metastatic colorectal cancer.
Clin Colorectal Cancer., Jul;6(2):125-32 (2006)
New agents do not necessarily mean progress: potential dangers of the dissecting sealer for pancreaticoduodenectomy.
J. Am. Coll. Surg., Aug;203(2):264; author reply 264-5 (2006)
Pancreaticoduodenectomy after placement of endobiliary metal stents.
J. Gastrointest. Surg., 10(7):1095; author reply 1096-7 (2006 Jul-Aug)
Colon carcinoma cells induce CXCL11-dependent migration of CXCR3-expressing cytotoxic T lymphocytes in organotypic culture.
Cancer Immunol. Immunother., Mar;56(3):359-70 (2007)
Partial stomach-partitioning gastrojejunostomy for malignant duodenal obstruction.
Am. J. Surg., Mar;191(3):428-32 (2006)
A multi-institutional phase II trial of preoperative full-dose gemcitabine and concurrent radiation for patients with potentially resectable pancreatic carcinoma.
Ann. Surg. Oncol., Feb;13(2):150-8 (2006)
CA 19-9 levels predict results of staging laparoscopy in pancreatic cancer.
J. Gastrointest. Surg., Dec;9(9):1286-92 (2005)
Pancreatic adenocarcinoma: Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw., Sep;3(5):598-626 (2005)
Hydronephrosis does not preclude curative resection of pelvic recurrences after colorectal surgery.
Ann. Surg. Oncol., Oct;12(10):786-92 (2005)
The association of cytokeratin-only-positive sentinel lymph nodes and subsequent metastases in breast cancer.
Am. J. Surg., May;189(5):606-9; discussion 609 (2005)
A challenge to the therapeutic nihilism of ESPAC-1.
Int. J. Radiat. Oncol. Biol. Phys., Mar;61(4):965-6 (2005)
Loss of methylthioadenosine phosphorylase and elevated ornithine decarboxylase is common in pancreatic cancer.
Clin. Cancer Res., Nov;10(21):7290-6 (2004)
Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas: analysis of histopathology and outcome.
Int J Gastrointest Cancer., 34(2-3):121-8 (2003)
Preoperative chemoradiation therapy for adenocarcinoma of the pancreas: The Fox Chase Cancer Center experience, 1986-2003.
Surg. Oncol. Clin. N. Am., Oct;13(4):685-96, x (2004)
Undetectable preoperative levels of serum CA 19-9 correlate with improved survival for patients with resectable pancreatic adenocarcinoma.
Ann. Surg. Oncol., Jul;11(7):644-9 (2004)
The metastatic/examined lymph node ratio is an important prognostic factor after pancreaticoduodenectomy for pancreatic adenocarcinoma.
Am Surg., Mar;70(3):235-40; discussion 240 (2004)
Peritoneal cytology in patients with potentially resectable adenocarcinoma of the pancreas.
Am Surg., Mar;70(3):208-13; discussion 213-4 (2004)
Neoadjuvant therapy and biliary decompression lower biliary and pancreatic juice vascular endothelial growth factor levels in patients with periampullary adenocarcinoma.
Am Surg., Feb;70(2):169-73; discussion 173-4 (2004)
Does no good deed go unpunished? Notes to a young surgeon.
Am Surg., Feb;70(2):97-100 (2004)
Is reporting of recurrence data important in pancreatic cancer?
Ann. Surg. Oncol., Mar;11(3):304-9 (2004)
Frequent activation of AKT2 kinase in human pancreatic carcinomas.
J. Cell. Biochem., 87(4):470-6 (2002)
Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region.
Ann. Surg., Nov;232(5):726-7 (2000)
Pancreatic carcinoma deemed unresectable at exploration may be resected for cure: an institutional experience.
Am Surg., Apr;66(4):378-85; discussion 386 (2000)
Local excision and chemoradiation for low rectal T1 and T2 cancers is an effective treatment.
Am Surg., Jul;65(7):625-30; discussion 630-1 (1999)
Preoperative chemotherapy of chemoradiotherapy for the treatment of adenocarcinoma of the pancreas and ampulla of Vater.
J Hepatobiliary Pancreat Surg., 5(3):251-4 (1998)
The presence of proliferative breast disease with atypia does not significantly influence outcome in early-stage invasive breast cancer treated with conservative surgery and radiation.
Int. J. Radiat. Oncol. Biol. Phys., Aug;42(1):105-15 (1998)
Phase I dose escalating trial of hyperfractionated pre-operative chemoradiation for locally advanced rectal cancer.
Int. J. Radiat. Oncol. Biol. Phys., Aug;42(1):43-50 (1998)
Preoperative radiation therapy and chemotherapy for adenocarcinoma of the pancreas.
Hepatogastroenterology., 45(21):634-7 (1998 May-Jun)
Preoperative versus postoperative chemoradiation for patients with resected pancreatic adenocarcinoma.
Am Surg., Jul;64(7):686-92 (1998)
A close or positive margin after mastectomy is not an indication for chest wall irradiation except in women aged fifty or younger.
Int. J. Radiat. Oncol. Biol. Phys., Jun;41(3):599-605 (1998)
Comparison of liver function tests after hepatic lobectomy and hepatic wedge resection.
Am Surg., May;64(5):408-14 (1998)
Sphincter preservation in rectal cancer. Surgical considerations for local excision.
Semin Radiat Oncol., Jan;8(1):39-47 (1998)
Use of saline-filled tissue expanders to protect the small bowel from radiation.
Oncology (Williston Park, N.Y.)., Jan;12(1):51-4; discussion 54, 60, 62, passim (1998)
Phase II trial of preoperative radiation therapy and chemotherapy for patients with localized, resectable adenocarcinoma of the pancreas: an Eastern Cooperative Oncology Group Study.
J. Clin. Oncol., Jan;16(1):317-23 (1998)
Prediction of recurrence and survival by post-resection CA 19-9 values in patients with adenocarcinoma of the pancreas.
Ann. Surg. Oncol., 4(7):551-6 (1997 Oct-Nov)
Implications of fine-needle aspiration in patients with resectable pancreatic cancer.
Am Surg., Aug;63(8):675-9; discussion 679-80 (1997)
Results of conservative surgery and radiation for mammographically detected ductal carcinoma in situ (DCIS).
Int. J. Radiat. Oncol. Biol. Phys., Jul;38(5):949-57 (1997)
Identification of women with T1-T2 breast cancer at low risk of positive axillary nodes.
J Surg Oncol., May;65(1):34-9 (1997)
Cryosurgical ablation of hepatic metastases from colorectal carcinomas.
Am Surg., Jan;63(1):63-8 (1997)
Surgical management of pancreatic cancer.
Oncology (Williston Park, N.Y.)., Sep;10(9 Suppl):9-12 (1996)
Preoperative chemoradiotherapy for localized pancreatic carcinoma. A perspective.
Cancer., Aug;78(3 Suppl):592-7 (1996)
The impact of tamoxifen on breast recurrence, cosmesis, complications, and survival in estrogen receptor-positive early-stage breast cancer.
Int. J. Radiat. Oncol. Biol. Phys., Jul;35(4):669-77 (1996)
Preoperative chemoradiotherapy for rectal cancer.
Ann. Surg., Jul;224(1):109-10 (1996)
Atraumatic method of intraoperative retrograde transhepatic biliary stent insertion.
J Surg Oncol., May;62(1):10-4 (1996)
Does the placement of surgical clips within the excision cavity influence local control for patients treated with breast-conserving surgery and irradiation.
Int. J. Radiat. Oncol. Biol. Phys., Mar;34(5):1009-17 (1996)
Interleukin-2 activation of cytotoxic cells in postmastectomy seroma.
J. Surg. Res., Feb;61(1):89-96 (1996)
Wound complications after resection and immediate postoperative brachytherapy in the management of soft-tissue sarcomas.
Ann. Surg. Oncol., Jan;3(1):51-6 (1996)
Long-term follow-up of local excision and radiation therapy for invasive rectal cancer.
Dis. Colon Rectum., Nov;38(11):1193-9 (1995)
How accurate is size measurement of pancreas cancer masses by computed axial tomography (CT) scanning?
Am Surg., Aug;61(8):686-91 (1995)
Management of extremity soft tissue sarcomas with limb-sparing surgery and postoperative irradiation: do total dose, overall treatment time, and the surgery-radiotherapy interval impact on local control?
Int. J. Radiat. Oncol. Biol. Phys., Jul;32(4):969-76 (1995)
Reconstruction with myocutaneous flaps following resection of locally recurrent rectal cancer.
Am Surg., Jul;61(7):581-9 (1995)
Routine bone scanning in patients with T1 and T2 breast cancer: a waste of money.
Ann. Surg. Oncol., Jul;2(4):319-24 (1995)